NRIX

Nurix Therapeutics Inc.

Price

$27.79

return (12m)

182.42%

p/e

-8.71

p/bv

7.38

DIVIDEND YIELD

0.00%

NRIX price

Nurix Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NRIX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

19.04%

3 months

58.53%

1 year

182.42%

2 years

18.41%

5 years

-11.83%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals NRIX

Valuation

P/E

-8.71

Sector -4.38

Industry -4.38

P/BV

7.38

Sector 2.02

Industry 2.02

P/Revenue (PSR)

80.86

Sector -4.40

Industry -4.40

EV/EBITDA

-27.99

Sector -263.09

Industry -263.09

EV/EBIT

-26.85

Sector -702.90

Industry -702.90

P/EBITDA

-8.64

Sector -4.39

Industry -4.39

P/EBIT

-8.23

Sector -4.73

Industry -4.73

P/Total Assets

5.55

Sector 1.49

Industry 1.49

P/Net Current Assets

9.19

Sector -11.70

Industry -11.70

P/Working Capital

7.73

Sector -3.19

Industry -3.19

EPS

-3.08

Sector -2.14

Industry -2.14

BVPS

3.63

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-999.45%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-1,042.04%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

-84.78%

Sector -65.14%

Industry -65.14%

ROA

-63.74%

Sector -65.53%

Industry -65.53%

ROIC

-310.69%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.34

Sector 2.90

Industry 2.90

Net Debt / EBITDA

4.91

Sector -6.07

Industry -6.07

Net Debt / EBIT

4.71

Sector -8.26

Industry -8.26

Net Debt / Equity

-1.10

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.75

Sector 0.41

Industry 0.41

Liabilities/Assets

0.25

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

4.32%

Sector -

Industry -

5Y Earnings CAGR

23.84%

Sector -

Industry -

Fundamentals NRIX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NRIX Nurix Therapeutics Inc.	$27.79	172.32%	0.00%	-8.71	7.38	-84.78%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NRIX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nurix Therapeutics

Nurix Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

17 years

Founded: 2009

2020

Time since IPO - 6 years

103

Employees

Nurix Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.97 billion, with shareholders equity totaling $402.63 million.

The company employs approximately 103 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nurix Therapeutics Inc. reported $36.76 million in revenue, generating net income of $-341.34 million.

Key financial metrics include a P/E ratio of -8.71, a price-to-book (P/B) ratio of 7.38, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NRIX.

Market cap

$2.97 billion

Net worth

$402.63 million

$402,630,000.00

Assets

$535.54 million

$535,540,000.00

Total Shares Outstanding

111.00 million

111,000,000

Average Daily Trading Volume

$2.23 million

$2,229,716.00

Sector

Health Care

Industry

Biotechnology

NRIX

NRIX revenue and profits

Financial Results NRIX

DRAG THE FRAME TO SEE MORE DATA

NRIX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Nurix Therapeutics (NRIX) today?

A cotação de Nurix Therapeutics (NRIX) hoje está em US$ 27.79, com uma variação de 182.42% em relação ao último ano. A cotação de Nurix Therapeutics (NRIX) iniciou o ano negociando na casa dos US$ 18.97 e hoje está em US$ 27.79. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Nurix Therapeutics (NRIX) e dados de ações do Ibovespa e mercados internacionais.

Quando Nurix Therapeutics (NRIX) paga dividendos?

Nurix Therapeutics (NRIX) não distribuiu dividendos no último ano.

Is Nurix Therapeutics (NRIX) a good investment?

Atualmente, Nurix Therapeutics (NRIX) está cotada a US$ 27.79, com um P/L de -8.71, representando um desvio de -605% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 182.42 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 182.42%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nurix Therapeutics (NRIX) stock?

Investir em ações de Nurix Therapeutics (NRIX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Nurix Therapeutics (NRIX) yield today?

A rentabilidade de Nurix Therapeutics (NRIX) foi de 19.04% no último mês, 182.42% no último ano e -11.83% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Nurix Therapeutics (NRIX) hoje, o investimento total seria de US$ 2,779.00, com base na cotação atual de US$ 27.79.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 7,848.45
Em 5 anos: US$ 2,450.24
Em 10 anos: US$ 2,779.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NRIX

Nurix Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NRIX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NRIX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Nurix Therapeutics

Nurix Therapeutics Inc.

United States

17 years

2020

103

PROFIT X PRICE NRIX

Financial Results NRIX

NRIX cash flow

Asset, Revenue and Profit Growth - NRIX

NRIX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions